#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14074	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2331	732.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1831	1831	T	912	T,C,A	701,210,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14074	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2331	732.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1565	1565	C	895	C,T	894,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24072	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4175	719.0	0	.	n	.	0	T695C	SNP	695	695	T	1347	1347	C	807	C,T,G	804,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24072	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4175	719.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1989	1989	A	970	A,C	969,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24072	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4175	719.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2623	2623	C	914	C,T,G	911,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24072	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4175	719.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2697	2697	A	814	A,C,G	810,3,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24072	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4175	719.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3249	3249	C	840	C,T	839,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1930	folP	855	855	100.0	folP.l15.c4.ctg.1	2167	110.9	1	SNP	p	R229S	0	.	.	685	687	CGC	1351	1353	CGC	201;200;201	C;G;C	201;200;201	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4714	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	4061	144.8	1	SNP	p	S91F	0	.	.	271	273	TCC	941	943	TCC	174;173;170	T;C;C	174;173;170	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4714	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	4061	144.8	1	SNP	p	D95N	0	.	.	283	285	GAC	953	955	GAC	175;176;174	G;A;C,G	175;176;173,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4714	gyrA	2751	2751	99.89	gyrA.l15.c30.ctg.1	4061	144.8	1	SNP	p	D95G	0	.	.	283	285	GAC	953	955	GAC	175;176;174	G;A;C,G	175;176;173,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1662	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2001	103.6	0	.	p	.	0	S32W	NONSYN	94	96	TCG	750	752	TGG	151;151;155	T;G,T;G	151;150,1;155	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1662	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2001	103.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	891	893	AAT	190;190;194	A;A;T	190;190;194	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1662	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	2001	103.6	1	SNP	p	G45D	0	.	.	133	135	GGC	789	791	GGC	174;172;173	G;G;C	174;172;173	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	980	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1629	75.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4810	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3665	163.7	1	SNP	p	D86N	0	.	.	256	258	GAC	921	923	GAC	200;201;199	G;A;C	199;200;199	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4810	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3665	163.7	1	SNP	p	S88P	0	.	.	262	264	TCC	927	929	TCC	209;209;207	T;C;C	209;209;207	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3590	parE	1986	1986	100.0	parE.l15.c30.ctg.1	3351	133.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1945	1947	GGC	195;199;196	G,T;G;C,G	194,1;199;195,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1393	1395	GCA	223;221;222	G,T;C,G;A	222,1;219,1;221	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1396	1398	ATC	220;222;224	A,C;T;C,G	219,1;222;223,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1408	1410	GTG	228;229;228	G;T;G,C	228;229;226,2	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1408	1410	GTG	228;229;228	G;T;G,C	228;229;226,2	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1912	1914	ACC	185;187;186	A;C,T;C	185;186,1;186	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1966	1968	GCG	191;187;187	G;C;G,A,C	191;187;184,2,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1966	1968	GCG	191;187;187	G;C;G,A,C	191;187;184,2,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2089	2091	GGC	232;230;228	G;G;C,T	232;230;227,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2098	2100	GGC	231;231;230	G;G,A;C,T,G,A	231;230,1;227,1,1,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3812	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	171.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2116	2118	CTG	226;229;228	C;T,C;G,C	226;227,2;227,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5108	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3532	179.9	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1856	1858	CCG	236;238;237	C;C,G;G	236;237,1;237	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2132	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2356	113.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	618	620	GGC	145;148;149	G;G;C	145;148;149	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2132	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2356	113.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	800	800	C	140	C	140	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	T18M	NONSYN	52	54	ACG	742	744	ATG	223;222;222	A;T;G	223;222;222	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	R40T	NONSYN	118	120	CGG	808	810	ACA	207;208;210	A;C;A,G	207;208;208,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	E41D	NONSYN	121	123	GAA	811	813	GAC	214;214;215	G,T;A;C	213,1;214;215	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	V45S	NONSYN	133	135	GTT	823	825	AGT	220;221;224	A;G,A;T	220;220,1;224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	G46K	NONSYN	136	138	GGC	826	828	AAA	222;222;220	A;A;A	222;222;220	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	S54A	NONSYN	160	162	TCC	850	852	GCC	223;224;225	G;C;C,T	223;224;224,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	V98I	NONSYN	292	294	GTC	982	984	ATC	219;218;217	A;T;C	219;218;217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	G189N	NONSYN	565	567	GGC	1255	1257	AAC	208;209;206	A;A;C,A	208;209;205,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1315	1317	ATG	212;210;212	A,T;T;G,T	211,1;210;211,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	E210_Y211insR	INS	628	628	G	1318	1318	G	215	G	215	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1324	1324	T	213	T	213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	1	SNP	p	G120K	0	.	.	358	360	GGT	1048	1050	GGT	246;246;246	G;G;T,G	246;246;245,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	1	SNP	p	A121N	0	.	.	361	363	GCC	1051	1053	GCC	244;245;249	G;C,T,A;C	244;243,1,1;249	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2524	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2163	145.4	1	SNP	p	A121D	0	.	.	361	363	GCC	1051	1053	GCC	244;245;249	G;C,T,A;C	244;243,1,1;249	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	244	porB3	990	162	93.83	porB3.l15.c17.ctg.2	164	46.5	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	61;61;61	A;C;T	61;61;61	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	244	porB3	990	162	93.83	porB3.l15.c17.ctg.2	164	46.5	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	61;61;61	A;G;T	61;61;61	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	244	porB3	990	162	93.83	porB3.l15.c17.ctg.2	164	46.5	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	61;61;61	G;A;C	61;61;61	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	244	porB3	990	162	93.83	porB3.l15.c17.ctg.2	164	46.5	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	61;61;61	T;A;C	61;61;61	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9002	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5702	197.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1378	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1387	123.0	1	SNP	p	V57M	1	.	.	169	171	ATG	762	764	ATG	233;235;233	A;T,C;G,T	233;234,1;232,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1104	1106	ACG	962;956;946	A,C;C,G;G,C,A	961,1;954,2;943,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1125	1127	GAC	885;885;881	G,A;A,G,C,T;C,T,G,A	884,1;881,1,2,1;878,1,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1143	1145	ATG	846;844;836	A;T,A;G,A	846;841,3;835,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1155	1157	TCA	811;814;815	T,G,C;C,G,A;A,G	808,2,1;812,1,1;814,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1200	1202	CAG	742;738;736	C,T;A;G	741,1;738;736	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1221	1223	CTT	684;683;681	C,A;T,A,C;T,C	682,1;680,2,1;680,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1242	1244	AGT	710;716;719	A,T,C;G,C;T	708,1,1;715,1;719	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1311	1313	CCG	803;798;807	C,A;C,G,T,A;G	802,1;794,1,2,1;807	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1413	1415	TCG	1010;1012;1012	T,G;C,A;G,A,T	1008,2;1011,1;1008,3,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1584	1586	AAA	428;425;419	A;A;A,C	428;425;418,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1587	1589	AAG	415;416;404	A;A,G;G,C	415;414,2;403,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1602	1604	CAC	397;399;401	C,T;A;C,G	396,1;399;400,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1641	1643	GAA	507;508;508	G,A;A,C;A,T,G	506,1;507,1;506,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1719	1721	ACG	690;692;695	A;C,T;G,T	690;691,1;694,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1770	1772	ATT	807;810;809	A,C;T;T,C,A	806,1;810;807,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1773	1775	AGT	811;813;816	A,G;G,C,A;T,C,A	810,1;811,1,1;814,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1812	1814	CTA	839;842;842	C,A;T,C;A,G,T,C	838,1;841,1;836,1,2,2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1854	1856	AAT	838;826;825	A,G,C;A,G;T,C	836,1,1;825,1;823,2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1923	1925	TCA	777;774;771	T,G;C,G,A;A,C	776,1;772,1,1;770,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1947	1949	ATG	758;757;762	A;T,C;G	758;756,1;762	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2241	2243	ACC	904;901;903	A,C;C,G,A;C,A	903,1;897,2,2;902,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17756	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3193	693.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2337	2339	GAA	820;820;822	G,C;A,G;A	819,1;819,1;822	.	Tetracycline resistance
